News Center
Our People
The ACELYRIN Team
We are led by experienced biopharma executives with exceptional track records of building strong, innovative and diverse teams across the healthcare industry.
Shao-Lee Lin, MD, PhD
Founder and Chief Executive Officer
Melanie Gloria
Chief Operating Officer
Gil Labrucherie
Chief Financial Officer
Paul Peloso, MD, MSc
Chief Medical Officer
Ron Oyston
Chief People Officer
Mina Kim
Chief Legal and Administrative Officer
Ken Lock
Chief Commercial Officer
Izokibep - Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis 
Publication
Izokibep - Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis
Read more ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
Press Release
ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
Read more